More like this
Judge Brinkema Spares Google an AdX Breakup in Ad Tech Antitrust Case
Albert V. Bryan United States Courthouse, 401 Courthouse Square, Alexandria, VA 22314, United StatesGoogle…
CONFIRMED89% CONFIDENCE21 days agoThe court's order (ECF 1857) reads "Signed by District Judge Leonie M. Brinkema on 9/2/2026" and was entered on the docket 09/02/2026.[1]Judge Leonie Brinkema rejected the DOJ's bid to make Google sell its AdX ad exchange, ordering behavioral remedies overseen by a Monitor and Technical Committee instead. Google still stands found liable for monopolizing ad tech.0.67J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
CONFIRMED82% CONFIDENCE58 days agoJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.$5.5B0.62DePuy Synthes Separates From Johnson & Johnson
ESTIMATED71% CONFIDENCEin 281 daysJ&J's 10-Q for the quarter to 28 June 2026 targets "completion within 18 to 24 months after the initial announcement" of 14 October 2025 (mid-April to mid-October 2027), and CFO Joseph Wolk said in July that J&J "is on track for a mid-2027 separation" (Bloomberg); "mid-2027" is read as the middle of the year, 1 July 2027, which sits inside that window.[1]Johnson & Johnson's orthopaedics business is due to leave the group as DePuy Synthes - by tax-free spinoff or by sale, with Apollo in talks at about $20 billion - and J&J says it is on track for a mid-2027 separation.0.59J&J Completes Its $1 Billion Acquisition of Firefly Bio
CONFIRMED87% CONFIDENCE56 days ago"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.$1B0.59FTC v. Amazon Monopoly Trial Begins in Seattle
DELAYED5 months late69% CONFIDENCEin 187 daysJudge Chun's December 15, 2025 order moves the "Bench Trial" from "February 9, 2027" to "March 29, 2027" ("The Court approves the proposed schedule"), and the August 26, 2026 joint status report still lists "March 29, 2027 Bench Trial".[1]The FTC and state attorneys general take Amazon to a bench trial before Judge John Chun over claims it illegally keeps its online marketplace monopoly by overcharging sellers and punishing those who offer lower prices elsewhere. The trial has slipped twice from its original October 2026 date.0.57Judge Approves the DOJ's HPE-Juniper Settlement Over States' Objections
Robert F. Peckham United States Courthouse and Federal Building, 280 South 1st Street, San Jose, California 95113, United States
CONFIRMED85% CONFIDENCE42 days agoThe order granting the motion for entry of final judgment (Case 5:25-cv-00951-PCP, Document 482) is 'Filed 08/12/26' and signed 'Dated: August 12, 2026' by P. Casey Pitts; no time is given, so it is an all-day date.[1]Judge P. Casey Pitts entered the consent decree clearing HPE's Juniper Networks deal in a 41-page order that found DOJ leadership overrode its own antitrust staff, but held that 12 states and DC had not shown the Instant On sale and Mist source-code licence were against the public interest.0.57J&J Announces Plan to Spin Off DePuy Synthes
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
CONFIRMED90% CONFIDENCE344 days agoThe release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.Johnson & Johnson said it would separate its roughly $9.2 billion-a-year orthopaedics business into a standalone company called DePuy Synthes within 18 to 24 months, and named former Smith & Nephew chief Namal Nawana to run it.0.57FTC Widens Microsoft Antitrust Probe to Cloud Licensing and Copilot
Federal Trade Commission, 600 Pennsylvania Avenue Northwest, Washington, District of Columbia 20580, United StatesMicrosoft…
ESTIMATED67% CONFIDENCE222 days agoEstimated, per Bloomberg's exclusive of 13 February 2026 (3:15 PM UTC): the FTC "has issued civil investigative demands in recent weeks" - no day is given, so the pin sits on the day the escalation was first reported.[1]The FTC sent civil investigative demands to at least half a dozen Microsoft rivals, asking whether its licensing hobbles Windows and Office on other clouds and how it bundles AI, security and identity software.0.56Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer
CONFIRMED81% CONFIDENCE275 days agoThe Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.[1]A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.$1.6B0.55J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
CONFIRMED86% CONFIDENCE258 days agoJ&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.[1]Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.0.55J&J Enterprise Business Review (Investor Day)
SCHEDULED85% CONFIDENCEin 76 daysJ&J set the date itself: CFO Joseph Wolk said on the 15 July Q2 call "We look forward to sharing more on strategy, growth catalysts and a longer-term outlook at our Enterprise business review on December 8", and the source[1] reports he "expects to present stronger growth expectations at its Dec. 8 investor day"; no time or venue has been announced, so the pin sits at J&J's headquarters as an all-day date.Johnson & Johnson holds its first enterprise business review since December 2023, where CFO Joseph Wolk says it will set out growth above its 5% to 7% long-term target, with a clear line of sight to double digits by the end of the decade.0.55The Paramount-Warner Bros. Discovery Antitrust Trial Opens
Phillip Burton Federal Building & United States Courthouse, 450 Golden Gate Avenue, San Francisco, CA 94102, United States
SCHEDULED80% CONFIDENCEin 160 daysThe court fixed the dates: the trial is set to begin Tuesday 2 March 2027 and run 12 court days, ending 19 March, with a final pretrial conference on 24 February 2027.[1]Twelve state attorneys general led by California's Rob Bonta, and separately the Writers Guild of America, get their day in court against Paramount Skydance's $111bn acquisition of Warner Bros. Discovery. Judge Araceli Martinez-Olguin set 12 court days, and the merger is on hold behind the result.0.55
Amazon